10752919

Source:http://linkedlifedata.com/resource/pubmed/id/10752919

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004096, umls-concept:C0032861, umls-concept:C0073992, umls-concept:C0087111, umls-concept:C0524527, umls-concept:C1112870, umls-concept:C1707455
pubmed:issue	3
pubmed:dateCreated	2000-4-27
pubmed:abstractText	The efficacy and safety of the aerosol metered-dose inhaler (MDI) formulation of salmeterol for asthma symptoms have been established. Recently, salmeterol has been introduced as a micronized powder formulation administered via a breath-activated multidose powder inhaler (Diskus).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9503580
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aerosols, http://linkedlifedata.com/resource/pubmed/chemical/Albuterol, http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Powders, http://linkedlifedata.com/resource/pubmed/chemical/salmeterol
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1081-1206
pubmed:author	pubmed-author:ChervinskyPP, pubmed-author:DavisSS, pubmed-author:KreitzerSS, pubmed-author:LawrenceMM, pubmed-author:ReillyDD, pubmed-author:StahlEE, pubmed-author:WangYY, pubmed-author:WolffMM
pubmed:issnType	Print
pubmed:volume	84
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	334-40
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10752919-Adolescent, pubmed-meshheading:10752919-Adult, pubmed-meshheading:10752919-Aerosols, pubmed-meshheading:10752919-Aged, pubmed-meshheading:10752919-Albuterol, pubmed-meshheading:10752919-Asthma, pubmed-meshheading:10752919-Bronchodilator Agents, pubmed-meshheading:10752919-Child, pubmed-meshheading:10752919-Double-Blind Method, pubmed-meshheading:10752919-Electrocardiography, Ambulatory, pubmed-meshheading:10752919-Female, pubmed-meshheading:10752919-Forced Expiratory Volume, pubmed-meshheading:10752919-Heart Rate, pubmed-meshheading:10752919-Humans, pubmed-meshheading:10752919-Male, pubmed-meshheading:10752919-Middle Aged, pubmed-meshheading:10752919-Nebulizers and Vaporizers, pubmed-meshheading:10752919-Powders, pubmed-meshheading:10752919-Spirometry, pubmed-meshheading:10752919-Therapeutic Equivalency
pubmed:year	2000
pubmed:articleTitle	Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
pubmed:affiliation	Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose, California 95117, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study